skip to main content

DOE PAGESDOE PAGES

Title: Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone

Authors:
; ; ; ; ; ; ;
Publication Date:
Type:
Publisher's Accepted Manuscript
Journal Name:
Aquatic Toxicology
Additional Journal Information:
Journal Volume: 184; Journal Issue: C; Related Information: CHORUS Timestamp: 2018-09-04 22:50:55; Journal ID: ISSN 0166-445X
Publisher:
Elsevier
Sponsoring Org:
USDOE
Country of Publication:
Netherlands
Language:
English
OSTI Identifier:
1412021

Davis, J. M., Ekman, D. R., Skelton, D. M., LaLone, C. A., Ankley, G. T., Cavallin, J. E., Villeneuve, D. L., and Collette, T. W.. Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone. Netherlands: N. p., Web. doi:10.1016/j.aquatox.2017.01.001.
Davis, J. M., Ekman, D. R., Skelton, D. M., LaLone, C. A., Ankley, G. T., Cavallin, J. E., Villeneuve, D. L., & Collette, T. W.. Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone. Netherlands. doi:10.1016/j.aquatox.2017.01.001.
Davis, J. M., Ekman, D. R., Skelton, D. M., LaLone, C. A., Ankley, G. T., Cavallin, J. E., Villeneuve, D. L., and Collette, T. W.. 2017. "Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone". Netherlands. doi:10.1016/j.aquatox.2017.01.001.
@article{osti_1412021,
title = {Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone},
author = {Davis, J. M. and Ekman, D. R. and Skelton, D. M. and LaLone, C. A. and Ankley, G. T. and Cavallin, J. E. and Villeneuve, D. L. and Collette, T. W.},
abstractNote = {},
doi = {10.1016/j.aquatox.2017.01.001},
journal = {Aquatic Toxicology},
number = C,
volume = 184,
place = {Netherlands},
year = {2017},
month = {3}
}